Lapsed Jan 28, 2026 on the fee record · High confidence
20-year base term ended Nov 3, 2026
Third maintenance fee unpaid; grace period ended.
Filed Jun 8, 2010 as application 12/796,297 · Granted Jan 28, 2014
Base term, 20 years from filing, plus 18 days of patent term adjustment (USPTO delay)
Today
Lapsed Jan 28, 2026
2006
2026
Clock starts
Nov 3, 2006
Nov 3, 2006
No longer in force
Jan 28, 2026
Jan 28, 2026
Granted
Jan 28, 2014
Jan 28, 2014
Term would have run to
Nov 21, 2026
Nov 21, 2026
base term
patent term adjustment
after the term ends
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
18
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
Its term would have run to Nov 21, 2026: its 20-year base term plus 18 days of term adjustment for prosecution delay. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 3, 2006, when application 11/592,114, the earliest non-provisional in its chain, was filed (this one was filed Jun 8, 2010) | Nov 3, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +18 days, USPTO patent term adjustment record | Nov 21, 2026 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | lapsed Jan 28, 2026 | High confidence |
| Computed term end | The steps above, in order | Jan 28, 2026 | High confidence |
This family
| US 7,767,672 | In force no later than Nov 2026 | no later than Nov 2026 |
| US 8,637,511 | this patent Jan 2026 | Jan 2026 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 5, 2012 Reel 29406, frame 205 | Binch, Hayley | Vertex Pharmaceuticals Incorporated | Assignment of Assignor's Interest |
| Dec 5, 2012 Reel 29406, frame 263 | Vertex Pharmaceuticals (San Diego) LLC | Vertex Pharmaceuticals Incorporated | Assignment of Assignor's Interest |
| Dec 5, 2012 Reel 29406, frame 233 | Vertex Pharmaceuticals (Europe) Limited | Vertex Pharmaceuticals Incorporated | Assignment of Assignor's Interest |
| Dec 7, 2012 Reel 29423, frame 169 | Mortimore, Michael; Davis, Chris; Boyall, Dean; Everitt, Simon; Robinson, Daniel; Ramaya, Sharn; Fraysse, Damien; Studley, John; Miller, Andrew; O'donnell, Michael; Rutherford, Alistair; Pinder, Joanne | Vertex Pharmaceuticals (Europe) Limited | Assignment of Assignor's Interest |
| Jul 10, 2014 Reel 33292, frame 311 | Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (San Diego) LLC | Macquarie US Trading LLC | Security Interest |
| Oct 14, 2016 reel/frame not recorded | Macquarie US Trading LLC | Vertex Pharmaceuticals Incorporated | Release of Security Interest |
| Oct 14, 2016 reel/frame not recorded | Macquarie US Trading LLC | Vertex Pharmaceuticals (San Diego) LLC | Release of Security Interest |
| Oct 14, 2016 Reel 40357, frame 1 | Macquarie US Trading LLC | Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (San Diego) LLC | Release of Security Interest |
| Sep 20, 2023 Reel 64961, frame 663 | Binch, Hayley | Vertex Pharmaceuticals (San Diego) LLC | Corrective Assignment to Correct the Assignee's Name Previously Recorded at Reel: 029406 Frame: 0205. Assignor(S) Hereby Confirms the Assignment. |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Note
The 18 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
46
later US patents cite this one
That is top 25% of utility patents granted in 2014 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.